Global leader in developing wearable sensors and digital biomarker technologies for clinical trials
BioSensics is a global leader in wearable medical devices and digital health technologies for clinical trials, patient monitoring, and health assessment. Founded in 2007 by three Harvard University scientists, the company develops validated sensor systems and digital biomarkers targeting neurological, neuromuscular, and rare disorders. BioSensics products include wearable gait analysis devices and clinical trial data platforms used in research on Parkinson's, ALS, Huntington's, and other conditions.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountJan 2024
Sep 2023
Jan 2023
Sep 2017
Create a free account to see which investors have funded this company.
Create Free AccountFitness wearable company offering a subscription-based health tracker that measures strain, recov...
Digital healthcare platform connecting patients, hospitals, and doctors in China for online consu...
Digital health insurance company and healthcare super-app offering personalized health insurance,...
operates in the healthcare industry focusing on biotechnology business
Workforce mental health platform that uses AI-powered matching to connect employees with high-qua...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
